148 related articles for article (PubMed ID: 35212776)
1. Computed tomography-based radiomics signature as a pretreatment predictor of progression-free survival in locally advanced hypopharyngeal carcinoma with a different response to induction chemotherapy.
Liu X; Sun C; Long M; Yang Y; Lin P; Xia S; Shen W
Eur Arch Otorhinolaryngol; 2022 Jul; 279(7):3551-3562. PubMed ID: 35212776
[TBL] [Abstract][Full Text] [Related]
2. CT-based radiomics signature analysis for evaluation of response to induction chemotherapy and progression-free survival in locally advanced hypopharyngeal carcinoma.
Liu X; Long M; Sun C; Yang Y; Lin P; Shen Z; Xia S; Shen W
Eur Radiol; 2022 Nov; 32(11):7755-7766. PubMed ID: 35608663
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of the radiomics-based model in progression-free survival of hypopharyngeal cancer treated with chemoradiation.
Mo X; Wu X; Dong D; Guo B; Liang C; Luo X; Zhang B; Zhang L; Dong Y; Lian Z; Liu J; Pei S; Huang W; Ouyang F; Tian J; Zhang S
Eur Radiol; 2020 Feb; 30(2):833-843. PubMed ID: 31673835
[TBL] [Abstract][Full Text] [Related]
4. MRI-based radiomics nomogram may predict the response to induction chemotherapy and survival in locally advanced nasopharyngeal carcinoma.
Zhao L; Gong J; Xi Y; Xu M; Li C; Kang X; Yin Y; Qin W; Yin H; Shi M
Eur Radiol; 2020 Jan; 30(1):537-546. PubMed ID: 31372781
[TBL] [Abstract][Full Text] [Related]
5. A Radiomics Signature-Based Nomogram to Predict the Progression-Free Survival of Patients With Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Plus Radiofrequency Ablation.
Fang S; Lai L; Zhu J; Zheng L; Xu Y; Chen W; Wu F; Wu X; Chen M; Weng Q; Ji J; Zhao Z; Tu J
Front Mol Biosci; 2021; 8():662366. PubMed ID: 34532340
[No Abstract] [Full Text] [Related]
6. Delta-volume radiomics of induction chemotherapy to predict outcome of subsequent chemoradiotherapy for locally advanced hypopharyngeal cancer.
Su CW; Lee JC; Chang YF; Su NW; Lee PH; Dai KY; Tai HC; Leu YS; Chen YJ
Tumori; 2022 Oct; 108(5):450-460. PubMed ID: 34423708
[TBL] [Abstract][Full Text] [Related]
7. A Clinical-Radiomics Nomogram Based on Magnetic Resonance Imaging for Predicting Progression-Free Survival After Induction Chemotherapy in Nasopharyngeal Carcinoma.
Liu L; Pei W; Liao H; Wang Q; Gu D; Liu L; Su D; Jin G
Front Oncol; 2022; 12():792535. PubMed ID: 35814380
[TBL] [Abstract][Full Text] [Related]
8. Association of Computed Tomography Radiomics Signature with Progression-free Survival in Neuroblastoma Patients.
Wang H; Li T; Xie M; Si J; Qin J; Yang Y; Zhang L; Ding H; Chen X; He L
Clin Oncol (R Coll Radiol); 2023 Nov; 35(11):e639-e647. PubMed ID: 37349199
[TBL] [Abstract][Full Text] [Related]
9. Prognostic analysis and risk stratification of lung adenocarcinoma undergoing EGFR-TKI therapy with time-serial CT-based radiomics signature.
Zhang X; Lu B; Yang X; Lan D; Lin S; Zhou Z; Li K; Deng D; Peng P; Zeng Z; Long L
Eur Radiol; 2023 Feb; 33(2):825-835. PubMed ID: 36166088
[TBL] [Abstract][Full Text] [Related]
10. A radiomic signature as a non-invasive predictor of progression-free survival in patients with lower-grade gliomas.
Liu X; Li Y; Qian Z; Sun Z; Xu K; Wang K; Liu S; Fan X; Li S; Zhang Z; Jiang T; Wang Y
Neuroimage Clin; 2018; 20():1070-1077. PubMed ID: 30366279
[TBL] [Abstract][Full Text] [Related]
11. A CT-based deep learning radiomics nomogram for predicting the response to neoadjuvant chemotherapy in patients with locally advanced gastric cancer: A multicenter cohort study.
Cui Y; Zhang J; Li Z; Wei K; Lei Y; Ren J; Wu L; Shi Z; Meng X; Yang X; Gao X
EClinicalMedicine; 2022 Apr; 46():101348. PubMed ID: 35340629
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment MRI-Derived Radiomics May Evaluate the Response of Different Induction Chemotherapy Regimens in Locally advanced Nasopharyngeal Carcinoma.
Zhang L; Ye Z; Ruan L; Jiang M
Acad Radiol; 2020 Dec; 27(12):1655-1664. PubMed ID: 33004261
[TBL] [Abstract][Full Text] [Related]
13. Development and Validation of a Computed Tomography-Based Radiomics Signature to Predict Response to Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer.
Wang W; Peng Y; Feng X; Zhao Y; Seeruttun SR; Zhang J; Cheng Z; Li Y; Liu Z; Zhou Z
JAMA Netw Open; 2021 Aug; 4(8):e2121143. PubMed ID: 34410397
[TBL] [Abstract][Full Text] [Related]
14. MRI-based random survival Forest model improves prediction of progression-free survival to induction chemotherapy plus concurrent Chemoradiotherapy in Locoregionally Advanced nasopharyngeal carcinoma.
Pei W; Wang C; Liao H; Chen X; Wei Y; Huang X; Liang X; Bao H; Su D; Jin G
BMC Cancer; 2022 Jul; 22(1):739. PubMed ID: 35794590
[TBL] [Abstract][Full Text] [Related]
15. Development of a computed tomography-based radiomics nomogram for prediction of transarterial chemoembolization refractoriness in hepatocellular carcinoma.
Niu XK; He XF
World J Gastroenterol; 2021 Jan; 27(2):189-207. PubMed ID: 33510559
[TBL] [Abstract][Full Text] [Related]
16. Radiomics Nomogram for Predicting Locoregional Failure in Locally Advanced Non-small Cell Lung Cancer Treated with Definitive Chemoradiotherapy.
Chen X; Tong X; Qiu Q; Sun F; Yin Y; Gong G; Xing L; Sun X
Acad Radiol; 2022 Feb; 29 Suppl 2():S53-S61. PubMed ID: 33308945
[TBL] [Abstract][Full Text] [Related]
17. Early response evaluation using primary tumor and nodal imaging features to predict progression-free survival of locally advanced non-small cell lung cancer.
Zhang N; Liang R; Gensheimer MF; Guo M; Zhu H; Yu J; Diehn M; Loo BW; Li R; Wu J
Theranostics; 2020; 10(25):11707-11718. PubMed ID: 33052242
[TBL] [Abstract][Full Text] [Related]
18. A radiomics nomogram for the prediction of overall survival in patients with hepatocellular carcinoma after hepatectomy.
Liu Q; Li J; Liu F; Yang W; Ding J; Chen W; Wei Y; Li B; Zheng L
Cancer Imaging; 2020 Nov; 20(1):82. PubMed ID: 33198809
[TBL] [Abstract][Full Text] [Related]
19. Radiomics nomogram for preoperative prediction of progression-free survival using diffusion-weighted imaging in patients with muscle-invasive bladder cancer.
Zhang S; Song M; Zhao Y; Xu S; Sun Q; Zhai G; Liang D; Wu G; Li ZC
Eur J Radiol; 2020 Oct; 131():109219. PubMed ID: 32905953
[TBL] [Abstract][Full Text] [Related]
20. Development of a radiomics nomogram based on the 2D and 3D CT features to predict the survival of non-small cell lung cancer patients.
Yang L; Yang J; Zhou X; Huang L; Zhao W; Wang T; Zhuang J; Tian J
Eur Radiol; 2019 May; 29(5):2196-2206. PubMed ID: 30523451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
